SAFE-GUARD® (fenbendazole) EQUI-BITS®

Different mode of action is what makes SAFE-GUARD® (fenbendazole) so effective against the most dangerous parasites of the horse.

Nobivac® 3-Rabies CA

NOBIVAC 3-RABIES CA vaccine meets state guidelines and is approved for sale in California to protect pets against rabies.

NOBIVAC® 3-Rabies

NOBIVAC 3-RABIES vaccine provides protection against rabies in dogs and cats for at least three years, and ferrets for one year.

NOBIVAC® 1-Rabies

Show effective against rabies for one year protection in healthy dogs, cats and ferrets.

NOBIVAC® Edge Lepto 4

NOBIVAC EDGE LEPTO4 Vaccine is the only canine leptospirosis vaccine with two critical indications, available in 0.5 mL dose.

Gilvetmab

Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.

NOBIVAC EDGE® DAPPv

Approved for protection of healthy dogs against canine distemper, adenovirus (Type 1), CPIV and CPV.

Forte VII™

PANACUR® (fenbendazole) POWERPAC

PANACUR® (fenbendazole) Paste 10% is indicated for the control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early third stage (hypobiotic), late third stage and fourth stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum), and arteritis caused by fourth stage larvae of Strongylus vulgaris in horses.

PANACUR® (fenbendazole) Paste 10%

PANACUR® Paste 10% is indicated for the treatment and control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early third stage (hypobiotic), late third stage and fourth stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum), and for the control of arteritis caused by fourth stage larvae of Strongylus vulgaris in horses.

Nobivac® Puppy-DPv

For the vaccination of healthy puppies for the prevention of disease caused by canine distemper virus and CPV.

Nobivac® NXT FeLV

First and only non-adjuvanted feline leukemia virus (FeLV) vaccine built on RNA particle technology